Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study to Evaluate the Single-dose Pharmacokinetics and Safety of Ceftobiprole in Neonate and Infant Subjects Aged up to 3 Months Undergoing Treatment With Systemic Antibiotics

NCT02527681 is registered in ClinicalTrials.gov with Basilea Pharmaceutica as lead sponsor.

NCT NCT02527681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02527681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study to Evaluate the Single-dose Pharmacokinetics and Safety of Ceftobiprole in Neonate and Infant Subjects Aged up to 3 Months Undergoing Treatment With Systemic Antibiotics
Lead sponsor
Basilea Pharmaceutica
Phase
Phase 1
Overall status
Terminated
Start date
November 22, 2016
Completion date
February 25, 2020
Enrollment
15 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections